BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8993829)

  • 21. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
    Kranz A; Mayr U; Frank H; Waltenberger J
    Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Angiogenesis--vascular endothelial growth factor and its receptors].
    Shibuya M
    Hum Cell; 1999 Mar; 12(1):17-24. PubMed ID: 10457901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From angiogenesis to lymphangiogenesis.
    Plate K
    Nat Med; 2001 Feb; 7(2):151-2. PubMed ID: 11175837
    [No Abstract]   [Full Text] [Related]  

  • 25. Vascular endothelial growth factor and the regulation of angiogenesis.
    Ferrara N
    Recent Prog Horm Res; 2000; 55():15-35; discussion 35-6. PubMed ID: 11036931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental biology. Organs await blood vessels' go signal.
    Seydel C
    Science; 2001 Sep; 293(5539):2365. PubMed ID: 11577206
    [No Abstract]   [Full Text] [Related]  

  • 27. Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogene.
    Mühlner U; Möhle-Steinlein U; Wizigmann-Voos S; Christofori G; Risau W; Wagner EF
    Oncogene; 1999 Jul; 18(29):4200-10. PubMed ID: 10435633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Angiogenesis and tumor growth. Angiogenic factors and tumor growth].
    Plouet J
    Ann Pathol; 1999; 19(5 Suppl):S70-1. PubMed ID: 10599456
    [No Abstract]   [Full Text] [Related]  

  • 29. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.
    Takahashi T; Shibuya M
    Oncogene; 1997 May; 14(17):2079-89. PubMed ID: 9160888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies.
    Aiello LP
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1647-52. PubMed ID: 9286253
    [No Abstract]   [Full Text] [Related]  

  • 31. VEGFs, receptors and angiogenesis.
    Veikkola T; Alitalo K
    Semin Cancer Biol; 1999 Jun; 9(3):211-20. PubMed ID: 10343072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of VEGF-flt receptor system in normal and tumor angiogenesis.
    Shibuya M
    Adv Cancer Res; 1995; 67():281-316. PubMed ID: 8571818
    [No Abstract]   [Full Text] [Related]  

  • 33. [VEGF].
    Yoshiji H; Fukui H; Kuriyama S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():189-94. PubMed ID: 11761939
    [No Abstract]   [Full Text] [Related]  

  • 34. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction.
    Sato Y; Kanno S; Oda N; Abe M; Ito M; Shitara K; Shibuya M
    Ann N Y Acad Sci; 2000 May; 902():201-5; discussion 205-7. PubMed ID: 10865839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of angiopoietin-2 and vascular endothelial growth factor in mice cerebral cortex after permanent focal cerebral ischemia.
    Wang RG; Zhu XZ
    Acta Pharmacol Sin; 2002 May; 23(5):405-11. PubMed ID: 11978190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development.
    Carmeliet P; Collen D
    Curr Top Microbiol Immunol; 1999; 237():133-58. PubMed ID: 9893349
    [No Abstract]   [Full Text] [Related]  

  • 37. Vascular endothelial growth factor: basic biology and clinical implications.
    Ferrara N; Keyt B
    EXS; 1997; 79():209-32. PubMed ID: 9002234
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin.
    Carmeliet P; Collen D
    Ann N Y Acad Sci; 2000 May; 902():249-62; discussion 262-4. PubMed ID: 10865845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of tumor growth via inhibition of tumor angiogenesis.
    Plate KH
    Adv Exp Med Biol; 1998; 451():57-61. PubMed ID: 10026850
    [No Abstract]   [Full Text] [Related]  

  • 40. [Participation of the phosphatidylinositol-3-kinase/Akt/endothelial-nitric-oxide synthase signaling in the processes of angiogenesis and vascular remodeling].
    Morales M
    Nefrologia; 2002; 22 Suppl 5():13-6. PubMed ID: 12107910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.